Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Rocket Pharmaceuticals Receives FDA Fast Track and Orphan Drug Designations for RP-A601 Gene Therapy for PKP2 Arrhythmogenic Cardiomyopathy (ACM)
Rocket Pharmaceuticals, a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic […]
Azafaros Announces Enrollment of First Patient in Phase 2 RAINBOW Study Evaluating AZ-3102 in GM2 and NP-C Patients
Azafaros has announced that the first patient has been enrolled in its Phase 2 RAINBOW […]
Kate Therapeutics Debuts With $51 Million Series A to Develop Next-Generation Genetic Medicines to Treat Muscle and Heart Diseases
Kate Therapeutics, a next-generation gene therapy company, today emerged from stealth mode with a $51 […]
EpimAb Biotherapeutics Appoints Yonghong Zhu, M.D., Ph.D., as Chief Medical Officer
EpimAb Biotherapeutics, a clinical-stage biotechnology company specializing in the development of bispecific antibodies, today announced […]
Mendus and NorthX Biologics to Enter into Strategic Cell Therapy Manufacturing Alliance Supported by New Investor Flerie
Mendus AB, a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announces that it […]
SciTech Development Raises $2.73 Million in Oversubscribed Funding Round to Advance Clinical Trials for Cancer Treatment
SciTech Development has announced it has closed a $2.73M funding round, led by several prominent […]
Amarna Therapeutics Announces Appointment of Dr. Henk Streefkerk as New CEO
Amarna Therapeutics, a privately-held biotechnology company developing transformative gene therapies in a range of rare […]
Aegis Life Awarded Grant to Develop DNA-encoded Antibodies Against Infectious Diseases
Aegis Life and its parent company Entos Pharmaceuticals, a clinical-stage biotechnology company developing genetic medicines […]
New "AI Doctor" Predicts Hospital Readmission and Other Health Outcomes
An artificial intelligence (AI) computer program can read physicians’ notes to accurately estimate patients’ risk […]
Axol Bioscience Collaborates with StrataStem to Deliver Stem Cell-Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease
Axol Bioscience, a leading pluripotent stem cell technology provider for drug discovery has signed an […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more